A Study of Risperidone Monotherapy in Bipolar Anxiety
Status:
Completed
Trial end date:
2006-09-01
Target enrollment:
Participant gender:
Summary
The specific aim of this study is to evaluate the efficacy, tolerability, and safety of
risperidone monotherapy in the treatment of ambulatory bipolar disorder with comorbid
lifetime panic disorder or generalized anxiety disorder and current at least moderately
severe anxiety.